𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)

✍ Scribed by Deuffic-Burban, Sylvie; Schwarzinger, Michaël; Obach, Dorothée; Mallet, Vincent; Pol, Stanislas; Pageaux, Georges-Philippe; Canva, Valérie; Deltenre, Pierre; Roudot-Thoraval, Françoise; Larrey, Dominique; Dhumeaux, Daniel; Mathurin, Philippe; Yazdanpanah, Yazdan


Book ID
121532041
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
704 KB
Volume
61
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES